Ken Griffin Cutera Inc Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$0.66 - $1.67 $3,102 - $7,849	-4,700 Reduced 6.14%	71,800 $56,000
Q2 2024 Aug 14, 2024	SELL	$1.38 - $2.86 $51,611 - $106,964	-37,400 Reduced 32.84%	76,500 $115,000
Q1 2024 May 15, 2024	BUY	$1.39 - $4.79 $108,975 - $375,536	78,400 Added 220.85%	113,900 $167,000
Q4 2023 Feb 14, 2024	SELL	$1.68 - $5.33 $7,896 - $25,051	-4,700 Reduced 11.69%	35,500 $125,000
Q3 2023 Nov 14, 2023	BUY	$6.02 - $20.05 $158,326 - $527,315	26,300 Added 189.21%	40,200 $242,000
Q2 2023 Aug 14, 2023	BUY	$14.14 - $27.07 $138,572 - $265,286	9,800 Added 239.02%	13,900 $210,000
Q1 2023 May 15, 2023	SELL	$23.52 - $42.73 $37,632 - $68,368	-1,600 Reduced 28.07%	4,100 $96,000
Q4 2022 Feb 14, 2023	SELL	$39.63 - $51.65 $83,223 - $108,465	-2,100 Reduced 26.92%	5,700 $252,000
Q3 2022 Nov 14, 2022	SELL	$37.04 - $54.04 $33,336 - $48,636	-900 Reduced 10.34%	7,800 $356,000

7.58M

220K

292K

Ticker CUTR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,575,400
Market Cap $6.46M
Description
Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.